Ocugen, Inc. (OCGN) KPIs and segments

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30

$0.83−0.05 (-5.24%)

Close on Nov 13, 2026Market cap $280.72MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Ocugen's business

Coming soon

This tab will track the numbers specific to Ocugen's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?